| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.051 | 0.07 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |